# SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects

> **NCT05476107** · PHASE1 · COMPLETED · sponsor: **Applied Molecular Transport** · enrollment: 50 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AMT-126
- **DRUG:** Placebo
- **OTHER:** Radioactive Tablet (Part 2 Only)

## Key facts

- **NCT ID:** NCT05476107
- **Lead sponsor:** Applied Molecular Transport
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-26
- **Primary completion:** 2022-03-26
- **Final completion:** 2022-03-26
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05476107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05476107, "SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05476107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*